Nucleosides And Darunavir/Dolutegravir In Africa

Clinical trial NCT03988452 · UNKNOWN

Trial details

NCT number: NCT03988452
Sponsor: Makerere University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Human Immunodeficiency Virus

Start date: 2019-07-30
Primary completion: 2020-09-30
Enrollment: 465

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.